Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment /

This book focuses on mAbs targeting EGFR and HER2 and, in five chapters, summarizes information on the use of these mAbs in colorectal cancer, breast cancer, lung cancer, genitourinary cancers, tumors of the skin, the CNS and the head and neck, and gynecologic malignancies.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Future Medicine Ltd
Otros Autores: Vermorken, Jan B.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, England : Future Medicine Ltd (Unitec House, 2 Albert Place, London N3 1QB, UK), ©2013.
Colección:Future Science Group eBook collection,
Temas:
Monoclonal antibodies > Therapeutic use.
HER-2 gene.
HER-2 protein.
Epidermal growth factor.
Cancer > Chemotherapy.
Antibodies, Monoclonal > therapeutic use
ErbB Receptors
Neoplasms > drug therapy
Receptor, ErbB-2
Genes, erbB-2
Epidermal Growth Factor
Anticorps monoclonaux > Emploi en thérapeutique.
Gène HR2.
Facteur de croissance épidermique.
Cancer > Chimiothérapie.
Cancer > Chemotherapy
Epidermal growth factor
HER-2 gene
HER-2 protein
Monoclonal antibodies > Therapeutic use
Internet Resources.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / Jan B. Vermorken
  • Colorectal cancer / Christian Rolfo, Giuseppe Bronte, Antonio Russo & Marc Peeters
  • Breast cancer / Sevilay Altintas
  • Lung cancer and genitourinary cancers / Dirk Schrijvers
  • Tumors of the skin, the CNS and the head and neck / Pol Specenier
  • Gynecologic cancers / Jan B. Vermorken
  • Index.

Ejemplares similares